Zentalis Pharmaceuticals (NASDAQ:ZNTL – Get Free Report)‘s stock had its “outperform” rating reissued by research analysts at Wedbush in a research report issued to clients and investors on Thursday, Benzinga reports. They presently have a $38.00 price objective on the stock. Wedbush’s price objective indicates a potential upside of 43.40% from the stock’s current price. […]
Zentalis Pharmaceuticals (NASDAQ:ZNTL – Get Free Report)‘s stock had its “outperform” rating reissued by equities research analysts at Wedbush in a report released on Thursday, Benzinga reports. They presently have a $38.00 price target on the stock. Wedbush’s target price indicates a potential upside of 43.40% from the company’s current price. Other research analysts also […]
Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Get Free Report) has received an average recommendation of “Buy” from the six research firms that are covering the firm, MarketBeat reports. Six research analysts have rated the stock with a buy rating. The average 1-year target price among analysts that have issued ratings on the stock in the last […]
Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Get Rating) has been assigned a consensus recommendation of “Buy” from the eight ratings firms that are covering the stock, MarketBeat reports. Eight analysts have rated the stock with a buy rating. The average 1 year price objective among analysts that have issued ratings on the stock in the last […]
Zentalis Pharmaceuticals (NASDAQ:ZNTL – Get Rating) had its price target hoisted by Stifel Nicolaus from $45.00 to $50.00 in a research report sent to investors on Wednesday, The Fly reports. Other equities analysts also recently issued research reports about the stock. Wedbush raised their target price on shares of Zentalis Pharmaceuticals from $31.00 to $38.00 […]